The Journal of Association of Chest Physicians (Jan 2019)

Rifampicin-Induced Thrombocytopenia: A Rare Complication

  • Ravi Dosi,
  • Arun Chandelkar,
  • Arpit Jain,
  • Satish Motiwale,
  • Prakash Joshi,
  • Priyanshu Jain

DOI
https://doi.org/10.4103/jacp.jacp_8_18
Journal volume & issue
Vol. 7, no. 1
pp. 38 – 40

Abstract

Read online

Extensive clinical experience has shown that rifampicin is well tolerated, but on rare occasions, it can cause life-threatening adverse reactions such as acute renal failure and thrombocytopenia. Throbocytopenia is mostly encountered with isoniazid and pyrazinamide. Rifampicin is an essential component of the treatment regimen for tuberculosis. We are reporting a case of rifampicin-induced thrombocytopenia which was being treated for pulmonary tuberculosis. The physician treating tuberculosis patients must be aware of this rare life-threatening complication.

Keywords